- Previous Close
0.0170 - Open
0.0180 - Bid 0.0180 x --
- Ask 0.0190 x --
- Day's Range
0.0180 - 0.0180 - 52 Week Range
0.0130 - 0.0310 - Volume
151,111 - Avg. Volume
1,691,213 - Market Cap (intraday)
15.761M - Beta (5Y Monthly) -0.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is based in Netanya, Israel.
www.hera-med.comRecent News: HMD.AX
View More
Performance Overview: HMD.AX
Trailing total returns as of 3/5/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HMD.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HMD.AX
View MoreValuation Measures
Market Cap
14.89M
Enterprise Value
12.94M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.45
Price/Book (mrq)
8.33
Enterprise Value/Revenue
22.40
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-120.95%
Return on Equity (ttm)
-583.49%
Revenue (ttm)
486.98k
Net Income Avi to Common (ttm)
-6.73M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
1.41M
Total Debt/Equity (mrq)
16.42%
Levered Free Cash Flow (ttm)
-3.67M
Company Insights: HMD.AX
HMD.AX does not have Company Insights